nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—skin cancer	0.638	1	CbGaD
Tetrahydrobiopterin—TH—Dopamine metabolism—TYR—skin cancer	0.0234	0.302	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—nerve—skin cancer	0.0171	0.126	CbGeAlD
Tetrahydrobiopterin—NOS3—penis—skin cancer	0.0159	0.118	CbGeAlD
Tetrahydrobiopterin—NOS3—hindlimb—skin cancer	0.012	0.0888	CbGeAlD
Tetrahydrobiopterin—NOS3—appendage—skin cancer	0.0103	0.0762	CbGeAlD
Tetrahydrobiopterin—TH—nerve—skin cancer	0.00814	0.06	CbGeAlD
Tetrahydrobiopterin—TH—blood vessel—skin cancer	0.00639	0.0471	CbGeAlD
Tetrahydrobiopterin—NOS3—endothelium—skin cancer	0.00623	0.046	CbGeAlD
Tetrahydrobiopterin—NOS3—blood vessel—skin cancer	0.00575	0.0424	CbGeAlD
Tetrahydrobiopterin—TH—Dopaminergic Neurogenesis—GLI2—skin cancer	0.00522	0.0674	CbGpPWpGaD
Tetrahydrobiopterin—TH—Dopaminergic Neurogenesis—GLI1—skin cancer	0.00491	0.0634	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—leg—skin cancer	0.00427	0.0315	CbGeAlD
Tetrahydrobiopterin—NOS3—neck—skin cancer	0.00411	0.0303	CbGeAlD
Tetrahydrobiopterin—TPH1—head—skin cancer	0.00406	0.0299	CbGeAlD
Tetrahydrobiopterin—PTGS2—hindlimb—skin cancer	0.00382	0.0281	CbGeAlD
Tetrahydrobiopterin—TH—Dopaminergic Neurogenesis—SHH—skin cancer	0.00355	0.0458	CbGpPWpGaD
Tetrahydrobiopterin—Pharyngolaryngeal pain—Imiquimod—skin cancer	0.00351	0.0235	CcSEcCtD
Tetrahydrobiopterin—Laryngeal pain—Imiquimod—skin cancer	0.00347	0.0233	CcSEcCtD
Tetrahydrobiopterin—TH—connective tissue—skin cancer	0.00328	0.0242	CbGeAlD
Tetrahydrobiopterin—PTGS2—appendage—skin cancer	0.00327	0.0241	CbGeAlD
Tetrahydrobiopterin—PAH—head—skin cancer	0.00318	0.0235	CbGeAlD
Tetrahydrobiopterin—Abdominal pain upper—Vismodegib—skin cancer	0.00298	0.02	CcSEcCtD
Tetrahydrobiopterin—NOS3—connective tissue—skin cancer	0.00295	0.0217	CbGeAlD
Tetrahydrobiopterin—NOS3—epithelium—skin cancer	0.0028	0.0206	CbGeAlD
Tetrahydrobiopterin—PTGS2—skin epidermis—skin cancer	0.00272	0.0201	CbGeAlD
Tetrahydrobiopterin—Cardiovascular disorder—Imiquimod—skin cancer	0.00269	0.0181	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFR1 specific signals—RASA1—skin cancer	0.00251	0.0324	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—NKX2-1—skin cancer	0.00233	0.0301	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—lymphoid tissue—skin cancer	0.00216	0.0159	CbGeAlD
Tetrahydrobiopterin—NOS3—female reproductive system—skin cancer	0.00208	0.0153	CbGeAlD
Tetrahydrobiopterin—PTGS2—endothelium—skin cancer	0.00198	0.0146	CbGeAlD
Tetrahydrobiopterin—Malnutrition—Vismodegib—skin cancer	0.00196	0.0132	CcSEcCtD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—KRT14—skin cancer	0.00195	0.0252	CbGpPWpGaD
Tetrahydrobiopterin—TH—head—skin cancer	0.00193	0.0142	CbGeAlD
Tetrahydrobiopterin—Nasal congestion—Imiquimod—skin cancer	0.00189	0.0127	CcSEcCtD
Tetrahydrobiopterin—PTGS2—blood vessel—skin cancer	0.00182	0.0134	CbGeAlD
Tetrahydrobiopterin—NOS3—head—skin cancer	0.00174	0.0128	CbGeAlD
Tetrahydrobiopterin—Arthralgia—Vismodegib—skin cancer	0.00167	0.0112	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00166	0.0111	CcSEcCtD
Tetrahydrobiopterin—Irritability—Imiquimod—skin cancer	0.00164	0.011	CcSEcCtD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—RASA1—skin cancer	0.00162	0.021	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Vismodegib—skin cancer	0.00157	0.0106	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Vismodegib—skin cancer	0.00156	0.0105	CcSEcCtD
Tetrahydrobiopterin—Infestation—Vemurafenib—skin cancer	0.00155	0.0104	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Vemurafenib—skin cancer	0.00155	0.0104	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00146	0.00981	CcSEcCtD
Tetrahydrobiopterin—Respiratory failure—Temozolomide—skin cancer	0.00144	0.0097	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Vismodegib—skin cancer	0.00141	0.00947	CcSEcCtD
Tetrahydrobiopterin—Pharyngolaryngeal pain—Docetaxel—skin cancer	0.0014	0.00938	CcSEcCtD
Tetrahydrobiopterin—Laryngeal pain—Docetaxel—skin cancer	0.00138	0.00929	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Vismodegib—skin cancer	0.00138	0.00929	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Imiquimod—skin cancer	0.00138	0.00927	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Vemurafenib—skin cancer	0.00137	0.00922	CcSEcCtD
Tetrahydrobiopterin—TH—lymph node—skin cancer	0.00135	0.00997	CbGeAlD
Tetrahydrobiopterin—TH—Circadian rythm related genes—NKX2-1—skin cancer	0.00134	0.0173	CbGpPWpGaD
Tetrahydrobiopterin—Infestation NOS—Imiquimod—skin cancer	0.00132	0.00889	CcSEcCtD
Tetrahydrobiopterin—Infestation—Imiquimod—skin cancer	0.00132	0.00889	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Vismodegib—skin cancer	0.00131	0.0088	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Imiquimod—skin cancer	0.00131	0.00876	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Imiquimod—skin cancer	0.0013	0.00871	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Imiquimod—skin cancer	0.00129	0.00864	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Vismodegib—skin cancer	0.00127	0.00851	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Vemurafenib—skin cancer	0.00126	0.00843	CcSEcCtD
Tetrahydrobiopterin—NOS3—lymph node—skin cancer	0.00122	0.00897	CbGeAlD
Tetrahydrobiopterin—Malnutrition—Vemurafenib—skin cancer	0.00121	0.00815	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Imiquimod—skin cancer	0.00118	0.00792	CcSEcCtD
Tetrahydrobiopterin—Rhinorrhoea—Docetaxel—skin cancer	0.00116	0.00782	CcSEcCtD
Tetrahydrobiopterin—Nasal congestion—Temozolomide—skin cancer	0.00113	0.00759	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vismodegib—skin cancer	0.0011	0.00736	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Imiquimod—skin cancer	0.00107	0.00719	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—FOXO4—skin cancer	0.00107	0.0138	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Vemurafenib—skin cancer	0.00106	0.00711	CcSEcCtD
Tetrahydrobiopterin—Oropharyngeal pain—Docetaxel—skin cancer	0.00104	0.00697	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Imiquimod—skin cancer	0.00103	0.00695	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Vemurafenib—skin cancer	0.00103	0.00694	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00103	0.00689	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Vismodegib—skin cancer	0.00102	0.00684	CcSEcCtD
Tetrahydrobiopterin—Rash—Vismodegib—skin cancer	0.00101	0.00679	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vismodegib—skin cancer	0.00101	0.00678	CcSEcCtD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—CDK4—skin cancer	0.00101	0.013	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—skin cancer	0.000991	0.0128	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Vemurafenib—skin cancer	0.00099	0.00665	CcSEcCtD
Tetrahydrobiopterin—Infection—Vemurafenib—skin cancer	0.000984	0.00661	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Vemurafenib—skin cancer	0.000971	0.00652	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Vemurafenib—skin cancer	0.000962	0.00646	CcSEcCtD
Tetrahydrobiopterin—Respiratory failure—Docetaxel—skin cancer	0.000961	0.00645	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vismodegib—skin cancer	0.000952	0.00639	CcSEcCtD
Tetrahydrobiopterin—Agitation—Imiquimod—skin cancer	0.000951	0.00638	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.000949	0.00637	CcSEcCtD
Tetrahydrobiopterin—PTGS2—connective tissue—skin cancer	0.000934	0.00689	CbGeAlD
Tetrahydrobiopterin—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.000928	0.012	CbGpPWpGaD
Tetrahydrobiopterin—Acute coronary syndrome—Bleomycin—skin cancer	0.000928	0.00623	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Bleomycin—skin cancer	0.000922	0.00619	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Dactinomycin—skin cancer	0.00092	0.00618	CcSEcCtD
Tetrahydrobiopterin—Irritability—Fluorouracil—skin cancer	0.000906	0.00608	CcSEcCtD
Tetrahydrobiopterin—Cough—Imiquimod—skin cancer	0.000903	0.00606	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000902	0.00606	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Imiquimod—skin cancer	0.000897	0.00602	CcSEcCtD
Tetrahydrobiopterin—PTGS2—epithelium—skin cancer	0.000887	0.00654	CbGeAlD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—RASA1—skin cancer	0.000883	0.0114	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Imiquimod—skin cancer	0.000881	0.00591	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000875	0.00587	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000855	0.00574	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Fluorouracil—skin cancer	0.000849	0.0057	CcSEcCtD
Tetrahydrobiopterin—PTGS2—skin of body—skin cancer	0.000844	0.00622	CbGeAlD
Tetrahydrobiopterin—Infection—Imiquimod—skin cancer	0.000839	0.00563	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—RASA1—skin cancer	0.000834	0.0108	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Temozolomide—skin cancer	0.000832	0.00559	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Imiquimod—skin cancer	0.000828	0.00556	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Temozolomide—skin cancer	0.000827	0.00555	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Imiquimod—skin cancer	0.00082	0.00551	CcSEcCtD
Tetrahydrobiopterin—Infestation—Temozolomide—skin cancer	0.000794	0.00533	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Temozolomide—skin cancer	0.000794	0.00533	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Vemurafenib—skin cancer	0.000783	0.00526	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Dactinomycin—skin cancer	0.000782	0.00525	CcSEcCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—skin cancer	0.000774	0.01	CbGpPWpGaD
Tetrahydrobiopterin—Urinary tract infection—Temozolomide—skin cancer	0.000771	0.00518	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00077	0.00517	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000762	0.00512	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Imiquimod—skin cancer	0.000744	0.00499	CcSEcCtD
Tetrahydrobiopterin—Infestation—Fluorouracil—skin cancer	0.000731	0.00491	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Fluorouracil—skin cancer	0.000731	0.00491	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Vemurafenib—skin cancer	0.00073	0.0049	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Imiquimod—skin cancer	0.000729	0.0049	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Fluorouracil—skin cancer	0.000721	0.00484	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Fluorouracil—skin cancer	0.000717	0.00481	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Fluorouracil—skin cancer	0.000711	0.00477	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Temozolomide—skin cancer	0.000707	0.00475	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Temozolomide—skin cancer	0.000702	0.00471	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Imiquimod—skin cancer	0.000691	0.00464	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000685	0.0046	CcSEcCtD
Tetrahydrobiopterin—PTGS2—lymphoid tissue—skin cancer	0.000683	0.00504	CbGeAlD
Tetrahydrobiopterin—Diarrhoea—Vemurafenib—skin cancer	0.000678	0.00455	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—CDKN2A—skin cancer	0.000671	0.00866	CbGpPWpGaD
Tetrahydrobiopterin—Body temperature increased—Imiquimod—skin cancer	0.000668	0.00448	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Imiquimod—skin cancer	0.000668	0.00448	CcSEcCtD
Tetrahydrobiopterin—PTGS2—female reproductive system—skin cancer	0.000659	0.00486	CbGeAlD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—CDK4—skin cancer	0.000657	0.00849	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Vemurafenib—skin cancer	0.000655	0.0044	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Fluorouracil—skin cancer	0.000652	0.00437	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Temozolomide—skin cancer	0.000642	0.00431	CcSEcCtD
Tetrahydrobiopterin—Cough—Bleomycin—skin cancer	0.000642	0.00431	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—RASA1—skin cancer	0.000634	0.00819	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Vemurafenib—skin cancer	0.00063	0.00423	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Docetaxel—skin cancer	0.000626	0.0042	CcSEcCtD
Tetrahydrobiopterin—Rash—Vemurafenib—skin cancer	0.000625	0.00419	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vemurafenib—skin cancer	0.000624	0.00419	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Imiquimod—skin cancer	0.000622	0.00418	CcSEcCtD
Tetrahydrobiopterin—Headache—Vemurafenib—skin cancer	0.00062	0.00417	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Temozolomide—skin cancer	0.00062	0.00416	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Docetaxel—skin cancer	0.000612	0.00411	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Bleomycin—skin cancer	0.0006	0.00403	CcSEcCtD
Tetrahydrobiopterin—Infection—Bleomycin—skin cancer	0.000596	0.004	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vemurafenib—skin cancer	0.000588	0.00395	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Imiquimod—skin cancer	0.000578	0.00388	CcSEcCtD
Tetrahydrobiopterin—Agitation—Temozolomide—skin cancer	0.00057	0.00383	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Imiquimod—skin cancer	0.000559	0.00375	CcSEcCtD
Tetrahydrobiopterin—Infection—Dactinomycin—skin cancer	0.000556	0.00373	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Docetaxel—skin cancer	0.000554	0.00372	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—skin cancer	0.000551	0.00712	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—head—skin cancer	0.000551	0.00406	CbGeAlD
Tetrahydrobiopterin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000547	0.00367	CcSEcCtD
Tetrahydrobiopterin—Cough—Temozolomide—skin cancer	0.000541	0.00363	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Temozolomide—skin cancer	0.000537	0.00361	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Imiquimod—skin cancer	0.000537	0.00361	CcSEcCtD
Tetrahydrobiopterin—Rash—Imiquimod—skin cancer	0.000533	0.00358	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Imiquimod—skin cancer	0.000532	0.00357	CcSEcCtD
Tetrahydrobiopterin—Headache—Imiquimod—skin cancer	0.000529	0.00355	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Temozolomide—skin cancer	0.000528	0.00354	CcSEcCtD
Tetrahydrobiopterin—Infestation—Docetaxel—skin cancer	0.000528	0.00354	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Docetaxel—skin cancer	0.000528	0.00354	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000524	0.00352	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Docetaxel—skin cancer	0.00052	0.00349	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—FOXO4—skin cancer	0.00052	0.00672	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—NRAS—skin cancer	0.000519	0.0067	CbGpPWpGaD
Tetrahydrobiopterin—Myocardial infarction—Docetaxel—skin cancer	0.000517	0.00347	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00051	0.00342	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Temozolomide—skin cancer	0.000506	0.0034	CcSEcCtD
Tetrahydrobiopterin—Infection—Temozolomide—skin cancer	0.000503	0.00338	CcSEcCtD
Tetrahydrobiopterin—Nausea—Imiquimod—skin cancer	0.000502	0.00337	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Temozolomide—skin cancer	0.000496	0.00333	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Fluorouracil—skin cancer	0.000495	0.00332	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CSPG4—skin cancer	0.000495	0.00639	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Temozolomide—skin cancer	0.000492	0.0033	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—PLIN2—skin cancer	0.000477	0.00616	CbGpPWpGaD
Tetrahydrobiopterin—Body temperature increased—Bleomycin—skin cancer	0.000474	0.00318	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Docetaxel—skin cancer	0.00047	0.00316	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Docetaxel—skin cancer	0.000467	0.00313	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Fluorouracil—skin cancer	0.000466	0.00313	CcSEcCtD
Tetrahydrobiopterin—Infection—Fluorouracil—skin cancer	0.000463	0.00311	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000461	0.0031	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000458	0.00307	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Fluorouracil—skin cancer	0.000457	0.00307	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—KRAS—skin cancer	0.000447	0.00577	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Temozolomide—skin cancer	0.000446	0.00299	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Dactinomycin—skin cancer	0.000442	0.00297	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Dactinomycin—skin cancer	0.000442	0.00297	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Bleomycin—skin cancer	0.000442	0.00297	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000437	0.00293	CcSEcCtD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—BRAF—skin cancer	0.000433	0.00559	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Docetaxel—skin cancer	0.000427	0.00287	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000425	0.00285	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Temozolomide—skin cancer	0.000414	0.00278	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Docetaxel—skin cancer	0.000412	0.00277	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Dactinomycin—skin cancer	0.000412	0.00277	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Fluorouracil—skin cancer	0.000411	0.00276	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000403	0.0027	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Temozolomide—skin cancer	0.0004	0.00269	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Temozolomide—skin cancer	0.0004	0.00269	CcSEcCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—skin cancer	0.000394	0.0051	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—NRAS—skin cancer	0.000393	0.00508	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—IL6—skin cancer	0.000392	0.00506	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—lymph node—skin cancer	0.000386	0.00284	CbGeAlD
Tetrahydrobiopterin—TPH1—Metabolism—CSPG4—skin cancer	0.000384	0.00496	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Dactinomycin—skin cancer	0.000383	0.00257	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Bleomycin—skin cancer	0.000382	0.00256	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	0.00038	0.0049	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Bleomycin—skin cancer	0.000378	0.00254	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Bleomycin—skin cancer	0.000378	0.00254	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—CDK4—skin cancer	0.000377	0.00488	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—TP53—skin cancer	0.000373	0.00482	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Temozolomide—skin cancer	0.000373	0.0025	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Fluorouracil—skin cancer	0.000369	0.00247	CcSEcCtD
Tetrahydrobiopterin—Cough—Docetaxel—skin cancer	0.00036	0.00242	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Docetaxel—skin cancer	0.000357	0.0024	CcSEcCtD
Tetrahydrobiopterin—Nausea—Bleomycin—skin cancer	0.000356	0.00239	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Dactinomycin—skin cancer	0.000356	0.00239	CcSEcCtD
Tetrahydrobiopterin—Rash—Dactinomycin—skin cancer	0.000353	0.00237	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Docetaxel—skin cancer	0.000351	0.00236	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000349	0.00234	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—PLIN2—skin cancer	0.000349	0.0045	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Temozolomide—skin cancer	0.000346	0.00232	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RHOU—skin cancer	0.000346	0.00446	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Fluorouracil—skin cancer	0.000344	0.00231	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IL6—skin cancer	0.000342	0.00441	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—KRAS—skin cancer	0.000338	0.00437	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Docetaxel—skin cancer	0.000337	0.00226	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—CSPG4—skin cancer	0.000335	0.00433	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Temozolomide—skin cancer	0.000335	0.00225	CcSEcCtD
Tetrahydrobiopterin—Infection—Docetaxel—skin cancer	0.000334	0.00224	CcSEcCtD
Tetrahydrobiopterin—Nausea—Dactinomycin—skin cancer	0.000332	0.00223	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Docetaxel—skin cancer	0.00033	0.00222	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Docetaxel—skin cancer	0.000327	0.00219	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—skin cancer	0.000326	0.00421	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Temozolomide—skin cancer	0.000322	0.00216	CcSEcCtD
Tetrahydrobiopterin—Rash—Temozolomide—skin cancer	0.000319	0.00214	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Fluorouracil—skin cancer	0.000319	0.00214	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Temozolomide—skin cancer	0.000319	0.00214	CcSEcCtD
Tetrahydrobiopterin—Headache—Temozolomide—skin cancer	0.000317	0.00213	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL6—skin cancer	0.000313	0.00405	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Fluorouracil—skin cancer	0.000308	0.00207	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000307	0.00206	CcSEcCtD
Tetrahydrobiopterin—Nausea—Temozolomide—skin cancer	0.000301	0.00202	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Fluorouracil—skin cancer	0.000297	0.00199	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Docetaxel—skin cancer	0.000296	0.00199	CcSEcCtD
Tetrahydrobiopterin—Rash—Fluorouracil—skin cancer	0.000294	0.00197	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Fluorouracil—skin cancer	0.000294	0.00197	CcSEcCtD
Tetrahydrobiopterin—Headache—Fluorouracil—skin cancer	0.000292	0.00196	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Docetaxel—skin cancer	0.000291	0.00195	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—HRAS—skin cancer	0.000288	0.00372	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—CSPG4—skin cancer	0.000281	0.00363	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TP53—skin cancer	0.00028	0.00361	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Fluorouracil—skin cancer	0.000277	0.00186	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—IL6—skin cancer	0.000275	0.00356	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Docetaxel—skin cancer	0.000275	0.00185	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—BRAF—skin cancer	0.000275	0.00355	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—IL6—skin cancer	0.000275	0.00355	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PLIN2—skin cancer	0.000274	0.00354	CbGpPWpGaD
Tetrahydrobiopterin—Body temperature increased—Docetaxel—skin cancer	0.000266	0.00179	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Docetaxel—skin cancer	0.000266	0.00179	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—ENO2—skin cancer	0.000261	0.00337	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—IL6—skin cancer	0.000256	0.00331	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Docetaxel—skin cancer	0.000248	0.00166	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—NRAS—skin cancer	0.000241	0.00311	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—HRAS—skin cancer	0.000234	0.00303	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Docetaxel—skin cancer	0.00023	0.00155	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL6—skin cancer	0.000229	0.00296	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000229	0.00295	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—ENO2—skin cancer	0.000228	0.00295	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—SHH—skin cancer	0.000228	0.00295	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—NRAS—skin cancer	0.000227	0.00294	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Docetaxel—skin cancer	0.000223	0.00149	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—CSPG4—skin cancer	0.000221	0.00285	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000217	0.0028	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Docetaxel—skin cancer	0.000214	0.00144	CcSEcCtD
Tetrahydrobiopterin—Rash—Docetaxel—skin cancer	0.000212	0.00142	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Docetaxel—skin cancer	0.000212	0.00142	CcSEcCtD
Tetrahydrobiopterin—Headache—Docetaxel—skin cancer	0.000211	0.00142	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—KRAS—skin cancer	0.000207	0.00268	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Docetaxel—skin cancer	0.0002	0.00134	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—KRAS—skin cancer	0.000196	0.00253	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000194	0.0025	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—ENO2—skin cancer	0.000191	0.00247	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PLIN2—skin cancer	0.00019	0.00245	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—FOXO4—skin cancer	0.000186	0.0024	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	0.000184	0.00238	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CSPG4—skin cancer	0.000183	0.00236	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL6—skin cancer	0.00018	0.00232	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—HRAS—skin cancer	0.000176	0.00228	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000174	0.00225	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTCH2—skin cancer	0.000169	0.00218	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—IL6—skin cancer	0.000169	0.00218	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.000167	0.00215	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—HRAS—skin cancer	0.000166	0.00215	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CDKN2A—skin cancer	0.000164	0.00212	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CDK4—skin cancer	0.000164	0.00212	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TP53—skin cancer	0.000161	0.00207	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—IL6—skin cancer	0.000159	0.00206	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CSPG4—skin cancer	0.000153	0.00198	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—ERCC2—skin cancer	0.000152	0.00196	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ENO2—skin cancer	0.00015	0.00194	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—KRAS—skin cancer	0.000149	0.00192	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—IL6—skin cancer	0.000147	0.0019	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000142	0.00183	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—ERCC2—skin cancer	0.000132	0.00171	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GLI2—skin cancer	0.000128	0.00165	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—HRAS—skin cancer	0.000126	0.00163	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000125	0.00162	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SHH—skin cancer	0.000124	0.0016	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ENO2—skin cancer	0.000124	0.0016	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TERT—skin cancer	0.000124	0.0016	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MC1R—skin cancer	0.000122	0.00158	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GLI1—skin cancer	0.00012	0.00155	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—NRAS—skin cancer	0.00012	0.00154	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SUFU—skin cancer	0.000114	0.00147	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000111	0.00144	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—ERCC2—skin cancer	0.000111	0.00143	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ENO2—skin cancer	0.000104	0.00134	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—KRAS—skin cancer	0.000103	0.00133	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—FOXO4—skin cancer	0.000101	0.00131	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—BRAF—skin cancer	9.83e-05	0.00127	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PTGS2—skin cancer	9.1e-05	0.00118	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—HRAS—skin cancer	8.75e-05	0.00113	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ERCC2—skin cancer	8.71e-05	0.00113	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SHH—skin cancer	8.69e-05	0.00112	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RASA1—skin cancer	8.64e-05	0.00112	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SMO—skin cancer	8.24e-05	0.00106	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTCH1—skin cancer	8.24e-05	0.00106	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—IL6—skin cancer	8.07e-05	0.00104	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTGER4—skin cancer	8.02e-05	0.00104	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTGS2—skin cancer	7.94e-05	0.00103	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PLIN2—skin cancer	7.76e-05	0.001	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CSPG4—skin cancer	7.47e-05	0.000965	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERCC2—skin cancer	7.21e-05	0.000932	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FOXO4—skin cancer	7.09e-05	0.000916	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—skin cancer	6.97e-05	0.0009	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—NRAS—skin cancer	6.95e-05	0.000898	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TERT—skin cancer	6.76e-05	0.000873	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—skin cancer	6.65e-05	0.000859	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL6—skin cancer	6.38e-05	0.000824	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CSPG4—skin cancer	6.26e-05	0.000808	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NRAS—skin cancer	6.18e-05	0.000798	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ERCC2—skin cancer	6.04e-05	0.00078	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—KRAS—skin cancer	5.98e-05	0.000773	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—BRAF—skin cancer	5.35e-05	0.000692	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	5.33e-05	0.000689	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KRAS—skin cancer	5.32e-05	0.000687	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—skin cancer	5.32e-05	0.000687	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—skin cancer	5.22e-05	0.000675	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HRAS—skin cancer	5.08e-05	0.000657	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ENO2—skin cancer	5.08e-05	0.000656	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SHH—skin cancer	5.08e-05	0.000656	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	4.74e-05	0.000612	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TERT—skin cancer	4.73e-05	0.000612	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HRAS—skin cancer	4.52e-05	0.000584	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—skin cancer	4.33e-05	0.000559	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—skin cancer	4.32e-05	0.000559	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ENO2—skin cancer	4.25e-05	0.000549	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FOXO4—skin cancer	4.14e-05	0.000535	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BRAF—skin cancer	3.75e-05	0.000484	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—skin cancer	3.62e-05	0.000468	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NRAS—skin cancer	3.36e-05	0.000435	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERCC2—skin cancer	2.95e-05	0.000381	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KRAS—skin cancer	2.9e-05	0.000374	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TERT—skin cancer	2.76e-05	0.000357	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ERCC2—skin cancer	2.47e-05	0.000319	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HRAS—skin cancer	2.46e-05	0.000318	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NRAS—skin cancer	2.36e-05	0.000304	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—skin cancer	2.36e-05	0.000304	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BRAF—skin cancer	2.19e-05	0.000283	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KRAS—skin cancer	2.03e-05	0.000262	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—skin cancer	1.8e-05	0.000233	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HRAS—skin cancer	1.72e-05	0.000223	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—skin cancer	1.65e-05	0.000213	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NRAS—skin cancer	1.38e-05	0.000178	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KRAS—skin cancer	1.18e-05	0.000153	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HRAS—skin cancer	1.01e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—skin cancer	9.63e-06	0.000124	CbGpPWpGaD
